Director of Medical Communications

Director Of Medical Communications

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson's disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit. We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients' lives.

Key Responsibilities :

• Lead the creation and execution of the global medical communication strategy across BRTx pipeline development programs in neurology and ophthalmology.
• Develop high-quality, scientifically accurate medical content including slide decks, FAQs, publications, abstracts, posters, and manuscripts.
• Partner with Clinical Development, Early commercialization, Regulatory, Program Management, and Corporate Development to ensure consistency and alignment across all external communications.
• Lead the development and management of Scientific Communication Platforms (SCPs) and Lexicon / Glossary documents for bemdaneprocel and OPCT-001.
• Lead strategic publication planning and execution in alignment with GPP and ICMJE guidelines, corporate goals and goals of the Medical Affairs team.
• Support advisory boards.
• Lead strategic planning and execution of medical and scientific congresses, including abstract submissions, symposia, medical booth activities and KOL engagement.
• Support the development and maintenance of a dynamic KOL profiling strategy to identify, segment, and prioritize key external experts.
• Collaborate with internal stakeholders to develop training materials for field medical and commercial teams.
• Ensure all content is compliant with regulatory requirements and company standards.
• Manage external vendors and medical writers as needed.

Minimum Requirements :

BlueRock Therapeutics Company Culture Highlights :